A Phase I/II Clinical Trial Assessing Safety and Efficacy of Estetrol (E4) in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer
Phase of Trial: Phase I/II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Estetrol (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pantarhei Bioscience
- 01 Jun 2017 Status changed from not yet recruiting to recruiting.
- 06 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 1 May 2017.
- 08 Feb 2017 Planned number of patients changed from 53 to 18.